Cardinal Health, Inc. is an American multinational health care services company.
| Revenue (TTM) | $250.74B |
| Gross Profit (TTM) | $9.42B |
| EBITDA | $3.99B |
| Operating Margin | 1.41% |
| Return on Equity | 0.00% |
| Return on Assets | 3.60% |
| Revenue/Share (TTM) | $1056.84 |
| Book Value | $-12.05 |
| Price-to-Book | 16.07 |
| Price-to-Sales (TTM) | 0.22 |
| EV/Revenue | 0.243 |
| EV/EBITDA | 18.63 |
| Quarterly Earnings Growth (YoY) | -19.50% |
| Quarterly Revenue Growth (YoY) | 11.00% |
| Shares Outstanding | $234.21M |
| Float | $233.73M |
| % Insiders | 0.26% |
| % Institutions | 90.06% |
Volatility is currently contracting
DUBLIN, Ohio, July 9, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2026 on August 11, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
Cardinal Health (CAH) concluded the recent trading session at $237.15, signifying a -1.07% move from its prior day's close.
Cardinal Health receives a Buy rating, supported by defensive business fundamentals, strong adjusted EPS growth, and strategic expansion into specialty healthcare. CAH's Q3FY26 showed 11% revenue growth and 35% adjusted EPS growth, though GAAP results were pressured by higher costs and special items. Valuation is at a premium with a Forward P/E of 21.64x, justified by improving profitability and cash flow, but future upside depends on sustained margin gains.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
In the latest trading session, Cardinal Health (CAH) closed at $233.01, marking a +1.79% move from the previous day.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.
